Intellectual property audit, quantified mapping of exposures and a report directly usable by an investor. So you know what the investor will find, before they do.

An investor always opens the intellectual property file first. The engagement covers the five dimensions they will examine: trademarks, patents and trade secrets, copyrights, know-how, assignment and licence agreements. Each asset is attributed to its holder, qualified under its applicable regime, and set against the value it carries within the company.
Funding rounds, corporate structurings, acquisitions of intellectual property assets. Browse recent matters, organised by category of operation.
Whatever the size, every engagement follows the same progression. No action is undertaken until the scope is set.


Intellectual property and corporate law
Romain Waïss-Moreau practised for 13 years at leading firms before establishing his own Law firm. He works at the intersection of corporate law and intellectual property, for founders, executives and investors whose operations span France and the United States.
Depending on the geographic scope and the imminence of a transatlantic operation, the diagnostic takes one of these two forms. Fees agreed at scoping, quote issued before any start of work.
from
from
An investor audit examines intellectual property to identify the risks of the target, from the fund's side. The Protect diagnostic reads the same material from the executive's side: what should be consolidated as a priority, what can be presented as it stands, what must be accepted. The two perspectives are complementary.
Yes. The structure and depth of the report are calibrated to pass into the hands of an investor or an acquirer without rework. The American components (USPTO, WIPO Madrid) are presented in the format expected on the United States side. This is the very purpose of the transatlantic configuration.
The matter is qualified and quantified at read-out: financial impact, probability, severity. IP litigation is not handled directly. Referral to a top-tier IP litigation firm, with documented handover. The diagnostic becomes the foundation of the defence strategy, without replaying the audit.
A substantial interim version can be delivered for the first iteration with the investor, dense enough to frame the conversation. The final report is delivered afterwards, incorporating the questions raised by the fund during the exchange. No reformatting on your part.
A confidentiality undertaking is signed before scoping. Where an investor is identified, a specific confidentiality undertaking is signed for the operation. Sensitive exchanges are routed through an encrypted channel if the phase requires it. No item of the file leaves our systems.
If your IP firm coordinates closely with your corporate firm on cross-cutting matters (capital structure, strategic contracts, American exposure), nothing justifies a change. Where the two practices do not communicate, the Protect diagnostic brings both perspectives together in a single report, run by a single practitioner.
You set out your situation. We identify what structures your perimeter, what weakens it, and which decision should be taken first.